Author(s): Anita Nagargoje1, G. R. Mundhada2, S. B. Deshmukh3, A. V. Saboo4

OBJECTIVE: To estimate prevalence of psychiatric co-morbidity and its effect on quality of life in persons with Hansen’s disease.

METHOD: The study was conducted on around 80 persons above 18 year age with Hansen’s disease in out-patient department dermatology and in leprosy home. Participants were diagnosed cases of Hansen’s disease, selected randomly and were evaluated with socio demographic questionnaire, Duke’s general health questionnaire, DSM-5 self rated level 1 cross cutting symptom measure – adult and WHO-QOL-BREF. The period of data collection was from October 2014 to March 2015.

RESULTS: The assessment showed that prevalence of at least one psychiatric co morbidity was 83.75% (67/80 patients) and of these 67 patients 18(26.86%) have one diagnosis, 26(38.80%) have two diagnoses and 23(34.32%) have 3 or more psychiatric diagnoses. Among all depression was most prevalent (28.35%) mental disorder; followed by anxiety disorder (23.88%). Quality of life was significantly impaired in almost all persons with Hansen’s disease.

CONCLUSION: Persons with Hansen’s disease have significantly high prevalence of mental disorders which have much impact on their quality of life which were under diagnosed and thus remained untreated.

Global Tech Summit